Extracellular matrix metalloproteinase inducer (EMMPRIN) expression correlates positively with active angiogenesis and negatively with basic fibroblast growth factor expression in epithelial ovarian cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Extracellular matrix metalloproteinase inducer (EMMPRIN) expression correlates positively with active angiogenesis and negatively with basic fibroblast growth factor expression in epithelial ovarian cancer
Authors
Keywords
Extracellular matrix metalloproteinase inducer, EMMPRIN, Vascular endothelial growth factor, Basic fibroblast growth factor, Ovarian cancer, Angiogenesis
Journal
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume 140, Issue 3, Pages 361-369
Publisher
Springer Nature
Online
2013-12-27
DOI
10.1007/s00432-013-1569-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer-Associated Fibroblasts and Their Putative Role in Potentiating the Initiation and Development of Epithelial Ovarian Cancer
- (2015) Isaiah G. Schauer et al. NEOPLASIA
- The prognostic value of vascular endothelial growth factor in ovarian cancer: A systematic review and meta-analysis
- (2012) Lei Yu et al. GYNECOLOGIC ONCOLOGY
- Pilot study of CD147 protein expression in epithelial ovarian cancer using monoclonal antibody 12C3
- (2012) Kazu Ueda et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Beyond VEGF: Inhibition of the Fibroblast Growth Factor Pathway and Antiangiogenesis
- (2011) C. Lieu et al. CLINICAL CANCER RESEARCH
- Overview of anti-angiogenic agents in development for ovarian cancer
- (2011) Robert A. Burger GYNECOLOGIC ONCOLOGY
- Fibroblast Growth Factor Receptor Mediates Fibroblast-Dependent Growth in EMMPRIN-Depleted Head and Neck Cancer Tumor Cells
- (2011) Z. Liu et al. MOLECULAR CANCER RESEARCH
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase 3 Trial of Bevacizumab in Ovarian Cancer
- (2011) Timothy J. Perren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- EMMPRIN promotes angiogenesis through hypoxia-inducible factor-2 -mediated regulation of soluble VEGF isoforms and their receptor VEGFR-2
- (2009) F. Bougatef et al. BLOOD
- CD147 Impacts Angiogenesis and Metastasis Formation
- (2009) Heike Voigt et al. CANCER INVESTIGATION
- Upregulation of HAb18G/CD147 in activated human umbilical vein endothelial cells enhances the angiogenesis
- (2009) Yanke Chen et al. CANCER LETTERS
- Cancer associated fibroblasts (CAFs) in tumor microenvironment
- (2009) Fei Xing Frontiers in Bioscience-Landmark
- Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study
- (2009) Jennifer M. Rubatt et al. GYNECOLOGIC ONCOLOGY
- Vasculogenic mimicry of human ovarian cancer cells: Role of CD147
- (2009) Dolo INTERNATIONAL JOURNAL OF ONCOLOGY
- Endoglin (CD105): A Marker of Tumor Vasculature and Potential Target for Therapy
- (2008) N. A. Dallas et al. CLINICAL CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now